|
|
|
|
Vol. 54, Issue 5, 749-754, November 1998
Institute of Genetic Medicine, Departments of Pediatrics and
Medicine, The Johns Hopkins University School of Medicine,
Baltimore, Maryland 21287-3914
In response to hypoxia, mammalian cells express multiple gene
products [including erythropoietin (EPO) and vascular endothelial growth factor (VEGF)] that serve to increase O2 delivery,
as well as glucose transporters and glycolytic enzymes (such as enolase 1) that allow metabolic adaptation to decreased O2
availability. Increased transcription of the genes encoding these
proteins in hypoxic cells is mediated by hypoxia-inducible factor 1 (HIF-1), a basic helix-loop-helix transcription factor. Expression of
HIF-1 and downstream genes can also be induced by exposure of cells to
divalent metals (such as CoCl2) or iron chelators [such as desferrioxamine (DFO)]. We report here that the organomercurial compound mersalyl induced expression of VEGF and enolase 1 mRNA, as
well as HIF-1 activity, in cultured cells. Expression of reporter genes
containing hypoxia response elements from the EPO and
VEGF genes was also induced by mersalyl treatment. However,
mersalyl inhibited endogenous EPO mRNA expression induced by hypoxia,
CoCl2, or DFO. In cells lacking expression of the
insulin-like growth factor-1 receptor, mersalyl did not induce HIF-1
activity or VEGF mRNA expression, whereas induction by hypoxia,
CoCl2, or DFO was unaffected. The mitogen-activated protein
kinase kinase inhibitor PD098059 markedly reduced induction of HIF-1 by
mersalyl but not by hypoxia. These results indicate that mersalyl
induces expression of HIF-1 and a subset of hypoxia-inducible genes by
a mechanism, involving the insulin-like growth factor-1 receptor and
mitogen-activated protein kinase activity, that is distinct from
mechanisms of induction by hypoxia, CoCl2, or DFO.
This article has been cited by other articles:
![]() |
C. Regazzetti, P. Peraldi, T. Gremeaux, R. Najem-Lendom, I. Ben-Sahra, M. Cormont, F. Bost, Y. Le Marchand-Brustel, J.-F. Tanti, and S. Giorgetti-Peraldi Hypoxia Decreases Insulin Signaling Pathways in Adipocytes Diabetes, January 1, 2009; 58(1): 95 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, and G. Cairo Role of HIF-1 and NF-{kappa}B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals J. Biol. Chem., July 25, 2008; 283(30): 20674 - 20686. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. De Ponti, R. Carini, E. Alchera, M. P. Nitti, M. Locati, E. Albano, G. Cairo, and L. Tacchini Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages J. Leukoc. Biol., August 1, 2007; 82(2): 392 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hanawa, M. Watanabe, Y. Karatsu, H. Fukuzawa, and Y. Shiraiwa Induction of a High-CO2-Inducible, Periplasmic Protein, H43, and its Application as a High-CO2-Responsive Marker for Study of the High-CO2-Sensing Mechanism in Chlamydomonas reinhardtii Plant Cell Physiol., February 1, 2007; 48(2): 299 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mylonis, G. Chachami, M. Samiotaki, G. Panayotou, E. Paraskeva, A. Kalousi, E. Georgatsou, S. Bonanou, and G. Simos Identification of MAPK Phosphorylation Sites and Their Role in the Localization and Activity of Hypoxia-inducible Factor-1{alpha} J. Biol. Chem., November 3, 2006; 281(44): 33095 - 33106. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wakisaka, S. Kondo, T. Yoshizaki, S. Murono, M. Furukawa, and J. S. Pagano Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1{alpha} Mol. Cell. Biol., June 15, 2004; 24(12): 5223 - 5234. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Powis and L. Kirkpatrick Hypoxia inducible factor-1{alpha} as a cancer drug target Mol. Cancer Ther., May 1, 2004; 3(5): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. WENGER Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB J, August 1, 2002; 16(10): 1151 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G. L. Semenza, and E. Van Obberghen Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway J. Biol. Chem., July 26, 2002; 277(31): 27975 - 27981. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jung, J. Haendeler, J. Hoffmann, A. Reissner, E. Dernbach, A. M. Zeiher, and S. Dimmeler Hypoxic Induction of the Hypoxia-Inducible Factor Is Mediated via the Adaptor Protein Shc in Endothelial Cells Circ. Res., July 12, 2002; 91(1): 38 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Obberghen Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products J. Biol. Chem., November 16, 2001; 276(47): 43836 - 43841. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, R. Guo, and J. A. Powell-Coffman The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia PNAS, June 20, 2001; (2001) 141234698. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Laughner, P. Taghavi, K. Chiles, P. C. Mahon, and G. L. Semenza HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1{alpha} (HIF-1{alpha}) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression Mol. Cell. Biol., June 15, 2001; 21(12): 3995 - 4004. [Abstract] [Full Text] |
||||
![]() |
A. Rajakumar, K. A. Whitelock, L. A. Weissfeld, A. R. Daftary, N. Markovic, and K. P. Conrad Selective Overexpression of the Hypoxia-Inducible Transcription Factor, HIF-2{{alpha}}, in Placentas from Women with Preeclampsia Biol Reprod, February 1, 2001; 64(2): 499 - 506. [Abstract] [Full Text] |
||||
![]() |
D. A. Elson, H. E. Ryan, J. W. Snow, R. Johnson, and J. M. Arbeit Coordinate Up-Regulation of Hypoxia Inducible Factor (HIF)-1{{alpha}} and HIF-1 Target Genes during Multi-Stage Epidermal Carcinogenesis and Wound Healing Cancer Res., November 1, 2000; 60(21): 6189 - 6195. [Abstract] [Full Text] |
||||
![]() |
G. L. Semenza HIF-1 and human disease: one highly involved factor Genes & Dev., August 15, 2000; 14(16): 1983 - 1991. [Full Text] |
||||
![]() |
R. M. Wanner, P. Spielmann, D. M. Stroka, G. Camenisch, I. Camenisch, A. Scheid, D. R. Houck, C. Bauer, M. Gassmann, and R. H. Wenger Epolones induce erythropoietin expression via hypoxia-inducible factor-1alpha activation Blood, August 15, 2000; 96(4): 1558 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.-M. Georgescu, J. W. Simons, and G. L. Semenza Modulation of Hypoxia-inducible Factor 1{{alpha}} Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics Cancer Res., March 1, 2000; 60(6): 1541 - 1545. [Abstract] [Full Text] |
||||
![]() |
R. Wenger Mammalian oxygen sensing, signalling and gene regulation J. Exp. Biol., January 4, 2000; 203(8): 1253 - 1263. [Abstract] [PDF] |
||||
![]() |
D. Feldser, F. Agani, N. V. Iyer, B. Pak, G. Ferreira, and G. L. Semenza Reciprocal Positive Regulation of Hypoxia-inducible Factor 1{{alpha}} and Insulin-like Growth Factor 2 Cancer Res., August 1, 1999; 59(16): 3915 - 3918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Richard, E. Berra, and J. Pouyssegur Nonhypoxic Pathway Mediates the Induction of Hypoxia-inducible Factor 1alpha in Vascular Smooth Muscle Cells J. Biol. Chem., August 25, 2000; 275(35): 26765 - 26771. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, R. Guo, and J. A. Powell-Coffman The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia PNAS, July 3, 2001; 98(14): 7916 - 7921. [Abstract] [Full Text] [PDF] |
||||